↓ Skip to main content

Dove Medical Press

Liposomal extended-release bupivacaine for postsurgical analgesia

Overview of attention for article published in Patient preference and adherence, September 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
2 X users
patent
3 patents

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
88 Mendeley
Title
Liposomal extended-release bupivacaine for postsurgical analgesia
Published in
Patient preference and adherence, September 2013
DOI 10.2147/ppa.s32175
Pubmed ID
Authors

Mark Lambrechts, Michael J O’Brien, Felix H Savoie, Zongbing You

Abstract

When physicians consider which analgesia to use postsurgery, the primary goal is to relieve pain with minimal adverse side effects. Bupivacaine, a commonly used analgesic, has been formulated into an aqueous suspension of multivesicular liposomes that provide long-lasting analgesia for up to 72 hours, while avoiding the adverse side effects of opioids. The increased efficacy of liposomal extended-release bupivacaine, compared to bupivacaine hydrochloride, has promoted its usage in a variety of surgeries including hemorrhoidectomy, bunionectomy, inguinal hernia repair, total knee arthroplasty, and augmentation mammoplasty. However, like other bupivacaine formulations, the liposomal extended-release bupivacaine does have some side effects. In this brief review, we provide an update of the current knowledge in the use of bupivacaine for postsurgical analgesia.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Russia 1 1%
France 1 1%
Romania 1 1%
Unknown 83 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 18%
Student > Postgraduate 10 11%
Other 9 10%
Student > Master 7 8%
Student > Doctoral Student 7 8%
Other 22 25%
Unknown 17 19%
Readers by discipline Count As %
Medicine and Dentistry 36 41%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Agricultural and Biological Sciences 5 6%
Nursing and Health Professions 4 5%
Veterinary Science and Veterinary Medicine 3 3%
Other 10 11%
Unknown 24 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2019.
All research outputs
#7,777,586
of 25,371,288 outputs
Outputs from Patient preference and adherence
#553
of 1,757 outputs
Outputs of similar age
#63,854
of 212,462 outputs
Outputs of similar age from Patient preference and adherence
#11
of 41 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,757 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,462 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.